MENU
ALVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alvotech (ALVO) Ownership - Who owns Alvotech?

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

Profile

Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.56B
P/E Ratio
21.72
Total Cash
42.85M
Projected Growth
N/A
Total Debt
1.28B
Revenue
570.95M
Risk (Beta)
-0.35
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
1.97 USD as % of share price

Fundamentals

ALVO
Capitalization
1.56B
P/E Ratio
21.72
Risk (Beta)
-0.35
Dividend Yield
N/A
Total Cash
42.8M
Total Cash/Share
0.14
Total Debt
1.28B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.97%
Revenue
571M
ROE
N/A
Book Value
-176.76M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.93M
Current Ratio
1.42
Current Revenue Per Employee
110217.05
Dividends Per Share - Security
N/A
EBITDA
113M
Float
N/A
Float - Current
N/A
Gross Income Margin
69.22
Revenue To Assets
5.26
Shares Held By Institutions
195M
Shares Outstanding - Current
312M
Total Liabilities
1.59B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-2.534
View a ticker or compare two or three
ALVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALVO showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com